About
Liposomal Drugs, Diagnostics
Areas of Focus
Categories
DiagnosticsSmall Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
3
As Collaborator
3
Total Enrollment
1,451
By Phase
PHASE2: 4EARLY_PHASE1: 1PHASE3: 1
By Status
COMPLETED: 4RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05309616Collaborator
Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis
PHASE2Recruiting
10 participants
Started: Feb 20, 2025 · Completed: Apr 30, 2026
NCT06233591Lead Sponsor
Evaluating LP-10 in Subjects With OLP
PHASE2Active, not recruiting
24 participants
Started: Jul 1, 2024 · Completed: Jun 1, 2025
NCT05811377Collaborator
Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay
EARLY_PHASE1Completed
8 participants
Started: Mar 29, 2023 · Completed: May 20, 2025
NCT03129126Lead Sponsor
The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
PHASE2Completed
13 participants
Started: Oct 1, 2020 · Completed: Sep 29, 2023
NCT01393223Lead Sponsor
Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome
PHASE2Completed
21 participants
Started: Jul 21, 2015 · Completed: Jun 14, 2018
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map
Loading map...